Related references
Note: Only part of the references are listed.Updated cost-effectiveness analysis of onabotulinumtoxinA for the prevention of headache in adults with chronic migraine who have previously received three or more preventive treatments in the UK
Georgia Hollier-Hann et al.
JOURNAL OF MEDICAL ECONOMICS (2020)
An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study
Fayyaz Ahmed et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Burden and costs of migraine in a Swedish defined patient population - a questionnaire-based study
Frida Hjalte et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level headache Centre
Andrea Negro et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
Andrew M. Blumenfeld et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Time Is Money: Investigating the Value of Leisure Time and Unpaid Work
Kaya Verbooy et al.
VALUE IN HEALTH (2018)
Patients' perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom
Pamela Vo et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Real-life use of onabotulinumtoxinA for symptom relief in patients with chronic migraine: REPOSE study methodology and baseline data
Brendan Davies et al.
JOURNAL OF HEADACHE AND PAIN (2017)
The cost effectiveness of Botox in Italian patients with chronic migraine
M. Ruggeri
NEUROLOGICAL SCIENCES (2014)
Assessing the performance of the EQ-VAS in the NHS PROMs programme
Yan Feng et al.
QUALITY OF LIFE RESEARCH (2014)
The International Classification of Headache Disorders, 3rd edition (beta version)
Andre Bes et al.
CEPHALALGIA (2013)
The cost-effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UK
Anthony J. Batty et al.
JOURNAL OF MEDICAL ECONOMICS (2013)
The cost of headache disorders in Europe: the Eurolight project
M. Linde et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS)
L. M. Bloudek et al.
JOURNAL OF HEADACHE AND PAIN (2012)
The Impact of Migraine and the Effect of Migraine Treatment on Workplace Productivity in the United States and Suggestions for Future Research
Wayne N. Burton et al.
MAYO CLINIC PROCEEDINGS (2012)
Mapping from Disease-Specific Measures to Health-State Utility Values in Individuals with Migraine
Patrick J. Gillard et al.
VALUE IN HEALTH (2012)
Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)
A. M. Blumenfeld et al.
CEPHALALGIA (2011)
OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56-Week PREEMPT Clinical Program
Sheena K. Aurora et al.
HEADACHE (2011)
EuroQol (EQ-5D) health utility scores for patients with migraine
Ruifeng Xu et al.
QUALITY OF LIFE RESEARCH (2011)
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
S. K. Aurora et al.
CEPHALALGIA (2010)
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
H. C. Diener et al.
CEPHALALGIA (2010)
OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program
David W. Dodick et al.
HEADACHE (2010)
Socio-Economic Factors, Lifestyle, and Headache Disorders - A Population-Based Study in Sweden
Anu Molarius et al.
HEADACHE (2008)
The impact of migraine on work, family, and leisure among young women - a multinational study
AN Dueland et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Attitudes and burden of disease among self-considered migraineurs -: a nation-wide population-based survey in Sweden
M Linde et al.
CEPHALALGIA (2004)
The economic burden of lost productivity due to migraine headache: A specific worksite analysis
WN Burton et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2002)
The impact of migraine on quality of life in the general population - The GEM study
GM Terwindt et al.
NEUROLOGY (2000)
Share Paper
